Strensiq 40 MG per 1 ML Injection
- RxCUI
- 1720276
- RxNorm name
- Strensiq 40 MG per 1 ML Injection
- Display name
- Strensiq 40 MG per 1 ML Injection
- Full name
- Strensiq 40 MG per 1 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:53
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125513 | Strensiq | asfotase alfa | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| STRENSIQ | ASFOTASE ALFA | Alexion Pharmaceuticals, Inc. | 3387574f-5eaa-4501-a71d-4cbfbd563031 | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | 1720276 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3387574f-5eaa-4501-a71d-4cbfbd563031 | Strensiq 40 MG per 1 ML Injection | SY | 18 | These highlights do not include all the information needed to use STRENSIQ safely and effectively. See full prescribing information for STRENSIQ. STRENSIQ ® (asfotase alfa) injection, for subcutaneous use Initial U.S. Approval: 2015 | 20251212 |
| 3387574f-5eaa-4501-a71d-4cbfbd563031 | Strensiq 40 MG in 1 ML Injection | PSN | 18 | These highlights do not include all the information needed to use STRENSIQ safely and effectively. See full prescribing information for STRENSIQ. STRENSIQ ® (asfotase alfa) injection, for subcutaneous use Initial U.S. Approval: 2015 | 20251212 |
| 3387574f-5eaa-4501-a71d-4cbfbd563031 | 1 ML asfotase alfa 40 MG/ML Injection [Strensiq] | SBD | 18 | These highlights do not include all the information needed to use STRENSIQ safely and effectively. See full prescribing information for STRENSIQ. STRENSIQ ® (asfotase alfa) injection, for subcutaneous use Initial U.S. Approval: 2015 | 20251212 |
| 3387574f-5eaa-4501-a71d-4cbfbd563031 | 1 ML Strensiq 40 MG/ML Injection | SY | 18 | These highlights do not include all the information needed to use STRENSIQ safely and effectively. See full prescribing information for STRENSIQ. STRENSIQ ® (asfotase alfa) injection, for subcutaneous use Initial U.S. Approval: 2015 | 20251212 |